PS
Pearce Samantha
Directeur Senior
OtherF
内部人交易记录
高级管理人员尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Pearce Samantha, Directeur Senior. Insider active across 1 company, notably Jazz Pharmaceuticals plc. Cumulatively, 23 reports have been recorded. History available since 3 March 2022. The latest transaction was filed on 5 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Pearce Samantha
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报23 总计
780 股@ US$261.620.0012% mcap5.8% 占其流量Ordinary SharesSEC:0001805688-26-000014:0
2,503 股@ US$188.6914.2% 占其流量Ordinary SharesSEC:0001805688-26-000006:0
9,782 股0Ordinary SharesSEC:0001805688-26-000004:0
3,637 股0Ordinary SharesSEC:0001805688-26-000002:0
577 股@ US$116.102.4% 占其流量Ordinary SharesSEC:0001765581-25-000051:0
1,905 股@ US$138.9510.4% 占其流量Ordinary SharesSEC:0001765581-25-000029:0
11,941 股0Ordinary SharesSEC:0001765581-25-000016:0
2,533 股0Ordinary SharesSEC:0001805688-25-000003:0
6,996 股0Ordinary SharesSEC:0001765581-24-000072:0
2,474 股@ US$117.5311.2% 占其流量Ordinary SharesSEC:0001765581-24-000035:0
5,065 股0Ordinary SharesSEC:0001765581-24-000022:0
2,210 股0Ordinary SharesSEC:0001784606-24-000012:0
3,870 股0Ordinary SharesSEC:0001765581-23-000019:0
531 股@ US$109.452.2% 占其流量Ordinary SharesSEC:0001765581-23-000008:0
531 股@ US$109.452.3% 占其流量Ordinary SharesSEC:0001765581-23-000004:0
531 股@ US$109.452.3% 占其流量Ordinary SharesSEC:0001765581-22-000140:0
532 股@ US$109.452.4% 占其流量Ordinary SharesSEC:0001765581-22-000120:0
531 股@ US$109.452.4% 占其流量Ordinary SharesSEC:0001765581-22-000109:0
531 股@ US$109.452.4% 占其流量Ordinary SharesSEC:0001765581-22-000075:0
532 股@ US$109.452.4% 占其流量Ordinary SharesSEC:0001765581-22-000071:0
8,508 股@ US$109.450.0061% mcap59.6% 占其流量Ordinary SharesSEC:0001765581-22-000065:0
5,835 股@ US$109.4519.7% 占其流量Ordinary SharesSEC:0001765581-22-000063:0
3,839 股0Ordinary SharesSEC:0001765581-22-000026:0
About Pearce Samantha
Pearce Samantha is Directeur Senior and serves as EVP, Chief Commercial Officer at Jazz Pharmaceuticals plc (XNAS). They have 22 filings in total, and across the recent sampled filings from 2022-03-09 to 2026-03-09, the volumes show EUR 0 of purchases and EUR 249082 of sales, with the dominant transaction nature listed as Attribuation.